Max Healthcare Board Approves FY26 Results, Recommends Dividend, Approves Lucknow Hospital Expansion
Max Healthcare announced audited FY26 results and recommended a final dividend of ₹2 per share. The Board approved Phase-I construction of a new hospital in Lucknow (capacity ~712 beds) and approved the re-appointment of Mr. Anil Kumar Bhatnagar as Director for three years.
The approval of financial results and dividend recommendation are material events for shareholders. The significant capital expenditure for a new hospital in Lucknow and the relocation of the registered office are also substantial corporate actions.
The announcement includes the approval of financial results, recommendation of a final dividend, approval for capacity expansion (new hospital construction), and re-appointment of a director, all of which are positive developments for the company.
Max Healthcare Institute Limited announced the outcome of its Board meeting held on May 21, 2026. The Board approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. The company recommended a final dividend of ₹2 per equity share (20% of face value) for the financial year 2025-26, subject to shareholder approval. This dividend will be paid/dispatched within 30 days from the conclusion of the forthcoming Annual General Meeting (AGM).
In other key decisions, the Board approved the construction of Phase-I of Max Super Specialty Hospital in Lucknow, which will accommodate approximately 712 beds. They also approved the shifting of the company's registered office from Maharashtra to Haryana, subject to member and regulatory approvals. Furthermore, the Board approved the re-appointment of Mr. Anil Kumar Bhatnagar as Non-Executive and Non-Independent Director for a further period of three years, effective October 1, 2026, subject to shareholder approval at the AGM.
The Board also considered and approved the request for re-classification of Radiant Life Care Hospital Foundation from ‘Promoter Group’ to ‘Public’ category, pending stock exchange approvals. The re-appointment of M/s. Chandra Wadhwa & Co. as Cost Auditors for the financial year 2026-27 was also approved. The financial results were accompanied by an auditor's report with an unmodified opinion. The Board meeting commenced at 12:07 pm IST and concluded at 3:44 pm IST.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.